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Critical Care Use during the Course of Serious Illness
Theodore J. Iwashyna
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Despite its expense and importance, it is unknown how common
critical care use is. We describe longitudinal patterns of critical care
use among a nationally representative cohort of elderly patients
monitored from the onset of common serious illnesses. A retrospec-
tive population-based cohort study of elderly patients in fee-for-
service Medicare is used, with 1,108,060 Medicare beneficiaries at
least 68 years of age and newly diagnosed with serious illnesses: 1
of 9 malignancies, stroke, congestive heart failure, hip fracture,
or myocardial infarction. Medicare inpatient hospital claims from
diagnosis until death (65.1%) or fixed-right censoring (more than
4 years) were reviewed. Distinct hospitalizations involving critical
care use (intensive care unit or critical care unit) were counted
and associated reimbursements were assessed; repeated use was
defined as five or more such hospitalizations. Of the cohort, 54.9%
used critical care at some time after diagnosis. Older patients were
much less likely to ever use critical care (odds ratio, 0.31; comparing
patients more than 90 years old with those 68–70 years old), even
after adjustment. A total of 31,348 patients (2.8%) were repeated
users of critical care; they accounted for $3.6 billion in hospital
charges and $1.4 billion in Medicare reimbursement. We conclude
that critical care use is common in serious chronic illness and is not
associated solely with preterminal hospitalizations. Use is uneven,
and a minority of patients who repeatedly use critical care account
for disproportionate costs.
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Critical care units represent the apex of technically intensive
(and expensive) American medicine. By some estimates, perhaps
20% of inpatient dollars—and perhaps 1% of the gross domestic
product—are spent in critical care units (1, 2). Such units inte-
grate many specialties and diverse technologies, offering the
possibility of survival to some patients who would otherwise die.
However, intensive care also raises the specter of treatment for
treatment’s sake (1) and fears of a life prolonged needlessly by
machines.
Most current approaches to studying this critical part of the
health care system treat an intensive care unit stay as a distinct,
self-contained event, somehow disconnected from the rest of
the patient’s experience. Exceptions include a few prominent
studies that have looked at the intensive care unit as a pretermi-
nal event (3) and a handful that have looked at so-called bounce-
back rates (readmissions within a few days) (4–8). Yet critical
care units are but one part of the medical armamentarium, and
they can also be studied in the context of the overall course of
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a patient’s disease. Thus, for different individuals or populations,
critical care could be used never or repeatedly over several years.
Studying critical care from this longitudinal perspective offers
complementary advantages relative to other approaches. Episode-
focused analyses naturally draw attention to those few patients
with unusually long or expensive stays, but they obscure the likeli-
hood that there also exist patients with repeated visits. More
generally, episode-focused approaches are disconnected from a
population at risk for critical care and so cannot provide informa-
tion about the population-based chances of critical care use (i.e.,
they are numerator-based rather than denominator-based stud-
ies). For example, they encourage a focus on short-term outcomes
that has only recently been overcome. Episode-focused analyses
prompt the oft-quoted statistic that 10–15% of all hospitalizations
result in critical care use (1, 9, 10). Studying critical care as a
preterminal event similarly provides a narrow time horizon and
prompts limited interest in the timing and frequency of critical care
use in the overall arc of disease. Such a focus can also contribute to
a misrepresentation of the nature of intensive care use: for exam-
ple, 46% of deaths in the Study to Understand Prognoses and
Preferences for Outcomes and Risks of Treatments (SUPPORT)
among gravely ill patients, including two enrollment diagnoses
requiring intensive care unit (ICU) admission, occurred within 3
days of receiving mechanical ventilation, and this can be (but
should not be) misconstrued to mean that nearly half of mechani-
cal ventilation use eventuates in death (3).
In the present article, we seek to extend prior work in impor-
tant ways. Here we consider critical care as an approach to
organizing the care of seriously ill elderly patients (1) and we
examine the following general hypotheses:
1. Among elderly patients with serious disease, critical care
use will be common; some patients will repeatedly use
critical care.
2. There will be significant demographic variation in the use
of critical care.
We address these questions from the perspective of an elderly
patient newly diagnosed with a serious—but not necessarily
terminal—illness, using a large, national cohort of patients.
Some parts of this work were previously presented in abstract
form at the 2004 American Thoracic Society International Meet-
ing in Orlando, Florida (11).
METHODS
Patient Population
To address these hypotheses, data are needed with the following proper-
ties: (1 ) the data should be based on an inception cohort of patients
monitored from the onset of their disease until death years later; (2 )
the data should include heterogeneous types of disease to help distin-
guish the needs engendered by particular pathophysiologies from
choices about care; and (3 ) the data should be broad in geographic scope
to monitor patients across distinct sites of care. Given the foregoing
parameters, we analyzed the Care after the Onset of Serious Illness
(COSI) data set, a data set built on the basis of Medicare claims.
Medicare data capture 96% of the American population older than 65
years (12). COSI is a population-based cohort of 1,164,790 elderly
patients identified at the time of initial diagnosis with a serious illness
in 1993: cancer of the lung, colon, pancreas, urinary tract, liver or biliary
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tract, head or neck, or central nervous system, as well as leukemia or
lymphoma, stroke, congestive heart failure, hip fracture, or myocardial
infarction. These diseases were chosen to represent diverse, common
illnesses that account for the majority of deaths in the United States;
we also required that these illnesses have an onset date that could be
reliably determined from Medicare claims (13). For inclusion in the
COSI sample patients had to be at least 68 years old to allow three
prior years of claims to be examined so as to reliably exclude prevalent
cases (14–18). Additional information on empanelment restrictions are
available (see the online supplement).
Patients in COSI were monitored through the end of 1997, by which
point nearly 65% had died. Patients were empaneled exclusively on
the basis of their claims up to cohort inception, without reference to
any future outcome or use of medical care.
Definition of Critical Care Hospitalization
Our outcome variable here is the use of critical care services during a
hospitalization, as similarly implemented by others (1, 19, 20). Medicare
defines critical care services as those provided in separate units with
round-the-clock nursing, equipment necessary to care for the critically
ill, and a nurse-to-patient ratio of no more than 1 to 2 (21); critical
care unit use is designated by hospitals, used for billing purposes, and
therefore subject to audit, verification, and substantial penalties for
fraud. This definition does not distinguish between coronary, surgical,
medical, and mixed-use critical care (1, 20, 22). By focusing on the use
of critical care during a hospitalization, rather than the number of days
it is used, we avoid the complications induced by interhospital variation
in the availability of other monitored settings (e.g., telemetry) that might
alter the timing of discharge from the unit, per se, without meaningfully
altering the intensity of service provided. Of note, our study design
allows us to track patients across multiple hospitals or states to assess
their frequency of repeated use.
Covariate Definitions
All other diseases that patients may have had beyond their primary
diagnosis (e.g., as noted on prior hospitalizations for other conditions)
were collected and treated as comorbidities, using an implementation
of the Charlson score (23–25). Sex, race/ethnicity, Medicaid receipt,
ZIP code median income, and charge and reimbursement data were
also developed from the claims. For additional details, with a discussion
of limitations, see the online supplement.
Statistical Methods
We use a variety of approaches to summarize the diverse distribution
of outcome variables present in the study: full distribution curves, counts
of use, and, for clarity, dichotomization into “no use” versus “any
use” (26, 27). For additional details on these methods, see the online
supplement.
RESULTS
Our sample consists of 1,108,060 patients newly diagnosed in
1993. The mean age was 79.0 ( 7.1 SD) years; 41.9% were
male; 88.3% were white; 15.8% received Medicaid benefits at
some point during 1993. Their index diagnoses and other descrip-
tive data are summarized in Table 1. Of the cohort, 65.1% died
before the end of follow-up; there was no loss to follow-up due
to the administrative nature of the records.
Overall Patterns of Use
Of the cohort, 54.9% used some critical care from diagnosis until
death or the end of follow-up (after at least 4 years). Figure 1A
shows the significant variation across diseases in patterns of
critical care use during the period of this study. Nearly all acute
myocardial infarction patients used at least one critical care
hospitalization at some point after their diagnosis. More than
half of patients with colon, head and neck, and CNS cancers
used critical care services at some point, as did congestive heart
failure patients. In every case, at least 30% experienced some
critical care. Therefore, a substantial minority, and in some cases
TABLE 1. COHORT DESCRIPTION*
Value Dead (% )†
Demographics
Age, yr [mean (SD)] 79.0 ( 7.1)
Male, % 41.9
Medicaid recipients, % 15.8









Myocardial infarction 17.9 56.0
Congestive heart failure 20.8 68.4




Head and neck 0.8 71.6






Urinary tract 3.1 58.4
* n  1,108,060.
† By the end of follow-up, after a minimum of 4 years and a maximum of
5 years of surveillance.
a majority, of patients with these common conditions ultimately
use critical care services. Similarly, as shown in Figure 1B, sig-
nificant critical care stays—that is, hospitalizations that included
at least 3 days of billed critical care—were not uncommon. More
than half of cardiac patients will experience such stays; between
one in four and one in five of other patients, including those
with hematologic malignancies, will experience such critical care.
As shown in Figure 2, critical care hospitalizations are com-
mon during the final 6 months of life among decedents, but a
focus on decedents underestimates the true longitudinal inci-
dence by up to half in some diseases. Of cohort members with
critical care use, 67.5% were still alive 6 months after discharge
from their first use. What is more, only 31.4% (349,443) of the
cohort’s critical care hospitalizations occurred during decedents’
final 6 months of life.
Overall in our cohort, 13.6% of critical care hospitalizations
ended in the death of the patient; hospitalizations involving at
least 3 days of billed critical care ended in death 13.2% of the
time.
Variation by Age and Other Demographic Variables
As shown in Table 2, there were significant differences in rates
of critical care use. Most strikingly, the odds of using critical
care declined markedly with age—patients over age 90 years
had less than one-third the odds of using critical care at any
point during the study period than did patients aged 68–70 years,
even after adjustment for baseline comorbidity. For example, in
unadjusted comparisons 47.6% of lung cancer patients aged
68–70 years used critical care at some point, whereas only 25.0%
of lung cancer patients aged 86–90 years and 20.7% of patients
aged 91 years and above did so. (This trend continued for all
age groups: 45.1% of patients 71–75 years of age; 39.8% of
patients 76–80 years of age; and 32.1% of patients 81–85 years
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Figure 1. Use of critical care
during serious illness (n 
1,108,060): percentage of
COSI cohort members, by pri-
mary diagnosis, who used any
critical care services from diag-
nosis until death or the end of
follow-up (maximum of 5
years of follow-up). Cancers of
organ systems are denoted by
the organ system name (e.g.,
CNS Ca  cancers of the central
nervous system). Number of
distinct hospitalizations involv-
ing critical care: open bars,
zero; light gray bars, one; dark
gray bars, two; solid bars, three
or more. MI  myocardial in-
farction; CHF  congestive
heart failure.
of age.) This pattern persisted in all disease-specific analyses
except for colon cancer, where patients 71–90 years of age
had 10–30% greater odds of requiring critical care than did 68-
to 70-year-olds; this effect occurred only during their initial
hospitalization.
African American, Asian American, and white elderly pa-
tients appear to use critical care similarly, and less than Hispanic
Americans. African Americans were overall more likely to use
critical care services (odds ratio, 1.09; 95% confidence interval,
1.07–1.10%) than white individuals in this cohort. A similar
absence of substantial difference occurs when comparing Asian
Americans with white Americans, albeit with limited sample
size for disease-specific analyses. In contrast, Hispanic American
elderly were more likely to use critical care services than were
white Americans (odds ratio, 1.49; 95% confidence interval,
1.44–1.53%)—statistically significantly so in 9 of 13 diagnoses,
Figure 2. Use of critical care in last 6 months of life by decedents. n 
721,794. Percentage of COSI cohort members, by primary diagnosis,
who used any critical care services during the last 6 months of their
life. COSI cohort members (35%) who did not die during the study
period are excluded. Cancers of organ systems are denoted by the
organ system name (e.g., CNS Ca  cancers of the central nervous system).
Number of distinct hospitalizations involving critical care: open bars,
zero; light gray bars, one; dark gray bars, two; solid bars, three or more.
with nonsignificant point estimates in the same direction in the
other 4 cases.
Impoverished patients—either those on Medicaid or those
who lived in ZIP codes with the lower two quintiles of income—
were less likely to ever use critical care (odds ratio, 0.87; 95%
confidence interval, 0.86–0.88% for Medicaid) after adjustment
for covariates. Men were somewhat more likely to use critical
care than were women (odds ratio, 1.18; 95% confidence interval,
1.17–1.19%) after adjustment for covariates.
Repeated Users of Critical Care
A total of 31,348 patients (2.8% of the cohort. 5.1% of all users
of critical care) were repeated users of critical care, defined as
having five or more distinct hospitalizations in which critical care
services were used between diagnosis and death or censoring
after no more than 5 years. These repeated users attended a
median of two different hospitals for their critical care stays;
34.2% used one, 24.1% used three or more. They accounted for




Odds Ratio Interval p Value
Age, yr
68–70* 1.00
71–75 0.93 0.92–0.95  0.0001
76–80 0.79 0.78–0.80  0.0001
81–85 0.63 0.63–0.64  0.0001
86–90 0.47 0.46–0.48  0.0001
 90 0.31 0.31–0.32  0.0001
Race
White* 1.00
African American 1.09 1.07–1.10  0.0001
Asian American 1.06 1.00–1.12 0.0573
Hispanic 1.49 1.44–1.53  0.0001
Other race 0.93 0.91–0.96  0.0001
Medicaid recipient (versus not) 0.87 0.86–0.88  0.0001
Men (versus women) 1.18 1.17–1.19  0.0001
All variables were run simultaneously in a logistic regression model that also
controlled for primary diagnosis, Charlson scores for 3 years before index hospital-
ization (each year represented by eight dummy variables), and ZIP code median
income. All patterns were confirmed in disease-specific regressions as discussed
in text.
* Comparison group.
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$3.66 billion in hospital charges and $1.45 billion in Medicare
reimbursement; these sums were 15% of all critical care hospital-
ization charges and reimbursement by the cohort. Furthermore,
this minority of users accounted for 23% of all critical care
hospitalizations by cohort members.
As seen in Table 3, in bivariate comparisons relative to other
cohort members, repeated users were more likely to be male
(46 versus 42%), Hispanic (3.6 versus 2.0%), younger (75.9 ver-
sus 79.1 years), and with higher baseline comorbidity (Charlson
score, 0.8 versus 0.5) (all p  0.001). Cardiac patients were
disproportionately represented (75 versus 38%). Among cancer
patients, those suffering from leukemia, lymphoma, colon can-
cer, and head and neck cancer were most likely to be repeated
users. These patterns persisted in multivariate analyses control-
ling for all measured factors (including Medicaid status and ZIP
code median income).
DISCUSSION
Here, we present the first nationwide longitudinal study of criti-
cal care use by seriously ill elderly patients in the United States.
There were three key findings in our inception cohort of 1.1 million
patients newly diagnosed with common serious illnesses in 1993
and monitored for up to 5 years. First, critical care use is quite
common, with half of patients with common cancers or stroke
requiring critical care within 5 years of diagnosis. Second, we
found that the odds of critical care use declined substantially with
increasing age. Third, we found that there exists a meaningful
population of repeated users of critical care—those 3% of pa-
tients averaging at least one visit per year for each of 5 years
accounted for more than $3 billion in hospital charges and ac-
counted for 23% of all critical care hospitalizations.
These three findings present a useful window through which
to view the differences between the longitudinal perspective
and other approaches to studying critical care. Episode-focused
analyses had indicated that 1 in 10 hospitalizations involved
critical care, and noted that this percentage naturally varied as
TABLE 3. CHARACTERISTICS OF REPEATED USERS
OF CRITICAL CARE
Repeat Users Others
(n  31,348) (n  1,076,712) p Value
Age, yr 75.9 79.1  0.0001
Male, % 46.4 41.7  0.0001
White, % 87.4 88.4  0.0001
African American, % 7.4 7.2 0.0673
Other race, % 1.1 2.0  0.0001
Asian American, % 0.5 0.5 0.7143
Hispanic, % 3.6 2.0  0.0001
On Medicaid, % 15.7 15.8 0.9284
Noncancers, %
AMI 44.3 17.1  0.0001
CHF 31.1 20.5  0.0001
Hip 4.5 17.8  0.0001
Stroke 11.9 20.3  0.0001
Cancers
CNS 0.1 0.5  0.0001
Head and neck 0.4 0.8  0.0001
Liver 0.1 0.7  0.0001
Colon 2.6 6.7  0.0001
Leukemia 0.7 1.7  0.0001
Lung 1.6 6.9  0.0001
Lymphoma 1.0 2.6  0.0001
Pancreas 0.1 1.3  0.0001
Urinary tract 1.6 3.2  0.0001
Mean 1-yr Charlson score 0.8 0.5  0.0001
Died before end of follow-up, % 54.4 65.5  0.0001
a function of the patient’s disease burden. It is likewise well
known that many serious diseases require multiple hospitaliza-
tions over several years of management. However, it has been
less appreciated that these facts together imply that the experi-
ence of critical care, far from being rare, may well be the modal
experience of patients with significant diseases. The diseases
represented in COSI include the top three causes of death in
the United States (28), and, moreover, are diseases with which
millions of Americans struggle for years. Thus, although few
Americans may use critical care in any given year, these data
make plausible the contention that a majority of Americans
likely will use critical care over the course of a life.
The relatively common use of critical care highlights differ-
ences from the perspective provided by SUPPORT. The focus
of SUPPORT on end-of-life care—with nine enrolling diagnoses
at five tertiary care centers carefully selected to yield an intended
50% 6-month mortality—meant that critical care would be
viewed as part of the dying process, a preterminal event. Our data
clearly show that critical care use, although certainly indicative of
serious illness, can also occur earlier in the course of disease;
more than two-thirds of patients will survive their critical care
hospitalization by more than 6 months. Critical care hospitaliza-
tions during the last 6 months of life are not “typical” critical
care visits, and, as such, care should be taken in generalizing
from the SUPPORT experiences of the gravely ill at five aca-
demic medical centers to all critical care services nationwide.
The generalizability of SUPPORT is of particular importance
as there were several troubling issues raised by SUPPORT, in-
cluding the quality of patient–physician communication about
preferences for aggressiveness of care (29) and the quality of pain
control at the end of life (3). SUPPORT also raised profound
concerns about differential treatment of the elderly. Several
studies have noted marked differences in rates of Do Not Resus-
citate orders as a function of age (30). Although some of these
differences appear to be a function of true differences in patient
preferences (30), there is also evidence that physicians tend to
underestimate the desire of the elderly for aggressive care (31).
These physician–patient disconnects may have measurable ad-
verse mortality impacts (32). More generally, there is evidence
that the elderly are treated less aggressively (33), despite the
significant evidence that age, per se, has a relatively minor impact
on the efficacy of critical care interventions (34–36). These past
studies have been limited to modest samples, typically in a few
institutions (33, 37, 38). Our data, although lacking detailed
preference information provided by SUPPORT, do strongly sus-
tain the concerns raised by SUPPORT and others about the
differential access of the elderly to potentially life-saving critical
care on a nationwide basis. These data reinforce the fact that the
failure of the SUPPORT intervention (3) only makes innovative
research on this issue all the more urgently needed.
In contrast to these marked age gradients, other demographic
factors were of modest importance. Race and ethnicity gradients
were clearly present, and ought be examined critically in light
of their pernicious pervasiveness in medicine (39). Nonetheless,
in magnitude they accord with certain other modest findings
(40). Similarly, potentially concerning lower levels of utilization
were found among the impoverished, which warrants further
examination; socioeconomic gradients have been found among
Do Not Resuscitate orders in other study populations (41).
More generally, the longitudinal perspective on critical care
research naturally draws attention to the possibility that there
would exist a subset of patients who disproportionately utilize
critical care resources. Episode-focused analyses have emphasized
that a minority of long-stay users account for perhaps one-quarter
or more of bed days in surgical ICUs (42). As others have empha-
sized, this is not only extremely expensive, but it also limits the
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access of other patients to potentially life-saving critical care nurs-
ing and beds (42). These long stays have also been identified as
“potentially ineffective care,” and have been the target of numer-
ous studies (9, 43, 44). Significant effort has been devoted to
finding lower intensity ways—such as intermediate care units or
long-term ventilatory facilities—to care for such patients without
compromising their health. The longitudinal focus identifies a
distinct but parallel subset of patients who use disproportionate
fractions of critical care resources, but divide them into many
stays, sometimes in multiple institutions. Although our data do
not allow us to reliably quantify the fraction of critical care days
for which they account, this small minority of patients accounted
for more than 20% of all critical care hospitalizations in the cohort.
What is more, they accounted for more than $3 billion in hospital
charges. Given, as well, the iatrogenic and nosocomial risks of
critical care (1, 45, 46), it raises the question of whether these
patients could be safely managed in lower acuity settings, as has
been done with guidelines stemming from individual episodes of
care (47–50). As cost control measures begin to be applied to
critical care services (51), the present data suggest that efforts to
better manage the longitudinal course of care of repeated users
could offer significant benefits. More finely grained longitudinal
patient data are necessary to identify repeated users so that pre-
vention of the need for critical care can be integrated into outpa-
tient multidisciplinary chronic disease management (52).
Limitations and Directions for Future Research
This work is subject to several limitations. First, we examined
longitudinal use of critical care pertaining only to 13 conditions
among the elderly. Although those conditions represent the most
common causes of death in the United States, they are not all-
inclusive of patients at risk for critical care use. In particular,
we have chosen a group of diseases that allow clear definition of
onset of disease within the measurement limitations of Medicare
claims; future work should relax this restriction to include other
important causes of ICU admission (and repeated admissions)
such as chronic obstructive pulmonary disease, liver disease, and
renal disease. Likewise, we studied only the elderly—clearly,
significant amounts of critical care may be used by those under
the age of 68 years. Regrettably, data to study national patterns
of health care utilization by young and middle-aged patients are
more scarce.
Second, by using Medicare claims we gain the benefits of
national enumerations and high data quality. However, we suffer
from disadvantages that require future work, including limited
clinical and social detail, and we have no separate information
about patient’s wishes (18). We cannot decompose “critical care
hospitalization” more finely, looking at precise indications (53)
or utilization of procedures (54).
Third, we have studied critical care hospitalizations, rather
than individual days spent in a given unit. Although this offers
us independence from known hospital-to-hospital variation in ICU
discharge patterns and variation resulting from high ICU bed
occupancy or limited availability in a given hospital, such detailed
local studies would clearly be of complementary value, particularly
in deriving implications for the practice of individual physicians
with particular patients. Similarly, as our focus in this article is
on longitudinal course, we have focused on whether patients ever
use critical care, and the number of times. Complementary studies
on rates of critical care use per unit time or per hospitalization
would be of value.
Finally, ours is an observational and descriptive study; as such,
we cannot say whether, in any substantial sense, the patterns we
observe are normatively the “right” ones. We have not addressed
outcomes of critical care, as others have done in more focused
studies (36, 55); the current study has not estimated the impact
of current patterns of critical care use on mortality or morbidity
of patients.
Despite its limitations, the longitudinal perspective offers a
complementary view to the study of critical care, and a frame-
work within which to integrate more focused studies. Others
have argued forcefully that critical care services need to be linked
to long-term outcomes, understanding diverse possibilities and
perspectives (56–58). The present work seeks to extend that
insight, to embed the common experience of critical care use
not only as the beginning of a process, but within the overriding
disease trajectory of seriously ill patients.
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